Compare Fiverr International Ltd (FVRR) vs Natera Inc. Common Stock (NTRA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fiverr International Ltd vs Natera Inc. Common Stock — how do they compare? Fiverr International Ltd trades at $8.56 (market cap $309.18M), while Natera Inc. Common Stock trades at $393.27 (market cap $57.03B). The key difference: Natera Inc. Common Stock is far larger — about 184.5× Fiverr International Ltd's market cap, and Natera Inc. Common Stock is trading nearer its 52-week high, Fiverr International Ltd nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Fiverr International Ltd for 62 Days and Natera Inc. Common Stock for 0 Days on average.
| FVRR | NTRA | |
|---|---|---|
Market Cap | $309.18M | $57.03B |
Volume | 481,205 | 1,131,157 |
Sector | Media | Health |
52-Week High | $23.60 | $425.64 |
52-Week Low | $8.47 | $179.42 |
Typical Hold Time | 62 Days | 0 Days |
Enterprise Value | $61.56M | $56.18B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Fiverr International (FVRR) trades at $8.55, down 0.81% with bearish technical signals despite attractive valuation metrics including a P/E of 10.62 and P/S of 0.75. Recent Q2 2026 earnings missed expectations with revenue declining 10% year-over-year as AI disruption pressures freelance demand. The company maintains strong gross margins of 82% but faces headwinds from accelerating AI adoption compressing lower-value freelance work.
While valuation appears compelling with consensus price target of $10.50 representing 23% upside, near-term risks from AI disruption and recent earnings misses warrant caution. Analyst sentiment leans neutral with 76% hold ratings, reflecting uncertainty around growth trajectory amid structural industry shifts. Cash flow trends show volatility with negative net cash flow projected for 2026.
NTRA trades at $395.66, down 0.53% today but remains near recent highs. The stock shows mixed technical signals with neutral momentum indicators. Fundamentally, the company demonstrates strong revenue growth ($2.31B in 2025, projected $2.7B in 2026) but continues to operate at a net loss (-$208M in 2025). Recent positive developments include FDA Breakthrough Device designation for its multi-cancer detection assay and regulatory approval in Japan for Signatera.
NTRA presents a growth story with significant analyst support (89% buy ratings) but carries execution risks. The stock trades at premium valuations (P/S 20.48) while still unprofitable. Key catalysts include clinical trial progress and international expansion, though investors face risks from ongoing losses and competitive pressures in precision medicine.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Fiverr International Ltd
Fiverr International Ltd is involved in buying and selling digital services in the same fashion as physical goods on an e-commerce platform. It is set out to design a digital marketplace that is built with a comprehensive SKU-like services catalog and a search, finds, and order process that mirrors a typical e-commerce transaction. The service offerings of the company include Graphics and Design, Digital Marketing, Writing and Translation, and Video and Animation among others.
Read more on FVRR →About Natera Inc. Common Stock
Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.
Read more on NTRA →
